In this feature John Baker, Head of Global Operations for the National Security and Resilience Consortium, and Colin Self, Emeritus Professor of Diagnostic and Therapeutic Technologies at the University of Newcastle upon Tyne’s Institute of Cellular Medicine and CEO of Selective Antibodies Ltd, examine the risk of bio threat to both global ...